Digestive remedies looked set to record constant value decline across most categories in 2021, though laxatives and antacids were expected to be exceptions. Despite price increases, the COVID-19 crisis was expected to have little impact on consumer purchasing behaviours.
Ranbaxy Laboratories Ltd, Dana Pharmaceuticals Ltd and Fidson Healthcare Plc compete for market share in antacids, with Ranbaxy Laboratories Ltd leading the category with its Gestid brand, which has established a large and loyal consumer base. Loyalty plays an important role in the brand’s sales, as consumers trust it to offer fast relief from heartburn and indigestion.
In the Nigerian market, chemists/pharmacies outlets continue to dominate the distribution of digestive remedies. Sales are being driven by an increase in the expansion of store networks, as consumers generally still prefer to buy their digestive remedies from such outlets due to the extensive selection of products they offer and their proximity to consumers’ homes.
Shifting lifestyles, driven by urbanisation, are leading to poor diets involving rising levels of junk food, and a move away from breastfeeding infants. During the forecast period, this is set to drive up demand for digestive remedies.
Rather than being used as a preventative treatment, digestive remedies products are typically used to provide instant relief from discomfort. As a result, consumers are more likely to purchase them at the nearest available location when needed.
During the review period, antacids accounted for the majority of total value sales of stomach treatments. Antacids manufacturers frequently come up with new formats, such as chewable and liquid suspension options, in order to maintain their competitive standing.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Digestive Remedies industry in Nigeria with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Digestive Remedies industry in Nigeria, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Digestive Remedies
Includes remedies designed and marketed to treat gastrointestinal problems.
See All of Our DefinitionsThis report originates from Passport, our Digestive Remedies research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!